| 发明名称 |
NOVEL PROGNOSTIC BIOMARKER IN ACUTE MYOCARDIAL INFARCTION |
| 摘要 |
A diagnostic method for determining prognosis of a myocardial infarcted patient, wherein the amounts of FXIII protein are determined on the day of myocardial infarction (t0) and at least on the following three days (t1 to t3), wherein a lowering of FXIII amount on any one of t0 to t3 below a threshold value is indicative of an increased risk of poor prognosis. |
| 申请公布号 |
US2015004625(A1) |
申请公布日期 |
2015.01.01 |
| 申请号 |
US201414316263 |
申请日期 |
2014.06.26 |
| 申请人 |
GEMMATI Donato |
发明人 |
GEMMATI Donato |
| 分类号 |
G01N33/573 |
主分类号 |
G01N33/573 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. Diagnostic kit for determining FXIII protein levels in biological samples of a myocardial infarcted patient, the kit comprising:
means for detecting the amount of FXIII protein in the biological samples, and at least four sample collecting tubes suitable to collect the at least four patient biological samples taken on the day of myocardial infarction (t0) and at least on the following three days (t1 to t3). |
| 地址 |
Ferrara IT |
